Jill Marie Broadfoot

Filings by Jill Marie Broadfoot span 3 companies, the busiest being aTYR PHARMA Inc, Fresh Tracks Therapeutics, Inc. and Talphera, Inc. Over a trading history stretching from 11 January 2010 to 22 June 2026, the count stands at 31 filings.

The open-market side counts 11 purchases for €89k alongside 6 sales for €16k. The net balance comes to €74k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants and 6 option exercises. 2026 to date brings no purchases and 1 sale.

A typical purchase (the median) is worth €6,964. Clusters matter here: 5 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

On 24 June 2026 came the latest disclosure, a share grant in Talphera, Inc. The last purchase on record was published on 3 June 2024, which is 873 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.